Excision recommended in high‐risk patients: revisiting the diagnosis of papilloma on core biopsy in the context of patient risk

YA Chen, JA Mack, DM Karamchandani… - The Breast …, 2019 - Wiley Online Library
We investigate the clinical history, past medical history, and risk status in women with benign
intraductal papillomas (IDP). We observed an upgrade rate of 3.9% to ductal carcinoma in …

Papillary lesions of the breast: to excise or observe?

S Khan, A Diaz, KJ Archer, RR Lehman… - The breast …, 2018 - Wiley Online Library
Papillary lesions of the breast range from benign to atypical to malignant. Although
papillomas without frank cancer are benign, their management remains controversial. When …

Intraductal papilloma on breast biopsy: upstaging rate and implications for practice guidelines

Y Jee, A Bakht, JM Burner, DL Coldren… - The American …, 2022 - journals.sagepub.com
Background The recommendation for management of intraductal papilloma has not been
clearly established and its surgical excision criteria remain controversial. This study …

Breast cancer risk associated with benign intraductal papillomas initially diagnosed on core needle biopsy

L Nasehi, CD Sturgis, N Sharma, P Turk… - Clinical Breast …, 2018 - Elsevier
Background The long-term risk for patients with benign intraductal papillomas (IDPs) on core
needle biopsy (CNB) who are not upgraded on excision is not well-defined. The goal of this …

[HTML][HTML] Audit on intraductal papilloma of the breast: upgrade rate, management pitfalls, and updated guidelines in a Tertiary Health Care Center

H Esmayil, S Abayazeed, M Hajaj - Cureus, 2021 - ncbi.nlm.nih.gov
Background Intraductal papillomas (IDPs) are typically classified as B3 lesions in histology
as they may show intralesional heterogeneity with a potential upgrade to malignancy. On …

Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy

M Rizzo, MJ Lund, G Oprea, M Schniederjan… - Annals of surgical …, 2008 - Springer
Background The clinical management of breast intraductal papilloma (IDP) remains
controversial. The objective of this study was to survey a large cohort of benign IDP …

Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors

H Corbin, P Bomeisl, AL Amin, HN Marshall, H Gilmore… - Human Pathology, 2022 - Elsevier
Surgical excision of breast intraductal papilloma (IDP) without atypia diagnosed on core
needle biopsy (CNB) is controversial as the risk of upgrade to malignant lesions is not well …

Papillary breast lesions: association with malignancy and upgrade rates on surgical excision

HT Tran, A Mursleen, S Mirpour… - The American …, 2017 - journals.sagepub.com
Intraductal papilloma falls under the category of benign breast mass. However, recent
studies show that it can harbor occult carcinoma. The management of benign intraductal …

Intraductal papilloma with benign pathology on breast core biopsy: to excise or not?

T Tatarian, C Sokas, M Rufail, M Lazar… - Annals of surgical …, 2016 - Springer
Background The management of intraductal papillomas on core biopsy continues to be
controversial. Papillomas with atypia are typically excised. However, it is unclear whether …

Non–mass-associated intraductal papillomas: is excision necessary?

PS Weisman, BJ Sutton, KP Siziopikou, N Hansen… - Human pathology, 2014 - Elsevier
Intraductal papillomas (IDPs) of the breast can be associated with a variety of clinical
symptoms and radiologic findings. Surgical excision is often recommended based on the …